Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

ClinicalTrials.gov ID: NCT06958211

Public ClinicalTrials.gov record NCT06958211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.

Study identification

NCT ID
NCT06958211
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
573 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 12, 2025 (Actual)
Primary completion
Oct 9, 2026 (Estimated)
Completion
Jul 11, 2027 (Estimated)
Last update posted
Jul 8, 2026

2025 – 2027

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Investigative Site US257 Birmingham Alabama 35203 —
Investigative Site US218 Birmingham Alabama 35244 —
Investigative Site US239 Montgomery Alabama 36117 —
Investigative Site US215 Phoenix Arizona 85006 —
Investigative Site US261 Phoenix Arizona 85037 —
Investigative Site US240 Tucson Arizona 85718 —
Investigative Site US262 Encino California 91436 —
Investigative Site US222 Fountain Valley California 92708 —
Investigative Site US211 Los Angeles California 90045 —
Investigative Site US237 Los Angeles California 90056 —
Investigative Site US234 Northridge California 91325 —
Investigative Site US250 Santa Ana California 92706 —
Investigative Site US244 Castle Rock Colorado 80109 —
Investigative Site US252 Cromwell Connecticut 06416 —
Investigative Site US208 Boca Raton Florida 33486 —
Investigative Site US203 Hialeah Florida 33012-3618 —
Investigative Site US258 Jacksonville Florida 32216 —
Investigative Site US206 Maitland Florida 32751 —
Investigative Site US223 Miami Florida 33136 —
Investigative Site US241 Miami Florida 33147 —
Investigative Site US202 Miami Florida 33173 —
Investigative Site US214 Tampa Florida 33609 —
Investigative Site US247 Tampa Florida 33612 —
Investigative Site US231 Columbus Georgia 31904 —
Investigative Site US225 Sandy Springs Georgia 30328 —
Investigative Site US207 Skokie Illinois 60077 —
Investigative Site US205 Plainfield Indiana 46168 —
Investigative Site US264 Lake Charles Louisiana 70601 —
Investigative Site US266 New Orleans Louisiana 70115 —
Investigative Site US254 Gambrills Maryland 21054 —
Investigative Site US201 Marriottsville Maryland 21104 —
Investigative Site US253 Milford Massachusetts 01757 —
Investigative Site US227 Needham Massachusetts 02492 —
Investigative Site US268 Worcester Massachusetts 01605 —
Investigative Site US238 Ann Arbor Michigan 48103 —
Investigative Site US230 Auburn Hills Michigan 48326 —
Investigative Site US251 St Louis Missouri 63110-1010 —
Investigative Site US271 Wildwood Missouri 63040 —
Investigative Site US212 Missoula Montana 59804 —
Investigative Site US216 Las Vegas Nevada 89145 —
Investigative Site US235 Hoboken New Jersey 07030 —
Investigative Site US217 Albuquerque New Mexico 87102 —
Investigative Site US219 Brooklyn New York 11203 —
Investigative Site US246 Elmhurst New York 11373 —
Investigative Site US269 Fairport New York 14450 —
Investigative Site US213 Kew Gardens New York 11415 —
Investigative Site US242 New York New York 10075 —
Investigative Site US245 Rochester New York 14620 —
Investigative Site US259 Huntersville North Carolina 28078 —
Investigative Site US263 Winston-Salem North Carolina 27104 —
Investigative Site US228 Cleveland Ohio 44124 —
Investigative Site US243 Columbus Ohio 43213 —
Investigative Site US249 Columbus Ohio 43213 —
Investigative Site US204 Portland Oregon 97201 —
Investigative Site US226 Plymouth Meeting Pennsylvania 19462 —
Investigative Site US256 Bluffton South Carolina 29910 —
Investigative Site US267 Mt. Pleasant South Carolina 29464 —
Investigative Site US255 Austin Texas 78759 —
Investigative Site US260 Cypress Texas 77429 —
Investigative Site US270 Prosper Texas 75078 —
Investigative Site US232 Sugar Land Texas 77479 —
Investigative Site US248 Arlington Virginia 22206 —
Investigative Site US209 Danville Virginia 24541 —
Investigative Site US229 Norfolk Virginia 23502 —
Investigative Site US265 Seattle Washington 98105 —
Investigative Site US224 Spokane Washington 99202 —
Investigative Site US210 Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06958211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06958211 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →